HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonino Carlo Privitera Selected Research

Antonino Carlo Privitera Research Topics

Disease

8Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 05/2017
5Crohn Disease (Crohn's Disease)
01/2022 - 01/2020
4Ulcerative Colitis
01/2021 - 12/2018
2COVID-19
04/2022 - 12/2020
1Pneumonia (Pneumonitis)
04/2022
1Spondylarthropathies
11/2020
1Necrosis
01/2020
1Hernia (Hernias)
01/2009
1Rectocele
07/2008

Drug/Important Bio-Agent (IBA)

4vedolizumabIBA
01/2022 - 01/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 01/2020
3Adalimumab (Humira)FDA Link
11/2021 - 12/2018
2Biosimilar PharmaceuticalsIBA
11/2021 - 01/2021
2Infliximab (Remicade)FDA Link
01/2021 - 05/2017
2golimumabFDA Link
01/2020 - 12/2018
1Immunomodulating AgentsIBA
04/2022
1SteroidsIBA
04/2022
1ABP 501IBA
11/2021
1CT-P13IBA
01/2021
1Ustekinumab (CNTO 1275)FDA Link
11/2020
1Monoclonal AntibodiesIBA
01/2020
1Polypropylenes (Polypropylene)IBA
01/2009
1parietexIBA
01/2009

Therapy/Procedure

3Therapeutics
12/2020 - 07/2008
1Psychology Biofeedback (Biofeedback)
07/2008